Product Description
CAS 191217-81-9 Pramipexole Treating Parkinson’ S and Bipolar Depression
Product Name | Pramipexole dihydrochloride monohydrate |
Appearance | White or off- white crystalline powder |
Assay | 99%min, 98.0% --101.0% |
Test | HPLC |
Certificate | ISO 9001 |
CAS | 191217-81-9 |
MF | C10H21Cl2N3OS |
Storage Temperature | Cool Dry Place |
Pramipexole dihydrochloride
Pramipexole dihydrochloride CAS No.: 191217-81-9
Pramipexole dihydrochloride Molecular Formula: C10H19Cl2N3S
Pramipexole dihydrochloride Molecular Weight: 284.25
Pramipexole dihydrochloride Melting point: 288-290°C
Pramipexole dihydrochloride Appearance: white crystalline powder
Standard: Enterprise Standard
Packing: 25KG/Drum or as per your requirements
Pramipexole dihydrochloride Application: Parkinson's syndrome
Category: Antiparkinsonian;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;APIs;Chiral Reagents;Sulfur Compounds;Parkinson's disease drug;pharmaceutical raw material;intermediate;API
Pramipexole dihydrochloride Use:
To alleviate the symptoms of Parkinson's disease: Parkinson's disease is due to the movement of brain dopaminergic neuron loss caused by dopamine deficiency, lead to patients with tremor, rigidity and bradykinesia and a series of symptoms. highly selective effects on dopamine D2 and D3 receptor agonist, dopamine release, improve motor symptoms. Research on Shannon display, early Parkinson's disease patients pramipexole monotherapy after, can effectively control the motor symptoms in patients with early stage, to help maintain the ability of daily life. Pramipexole in combination with levodopa can effectively improve the ADL score and motor symptoms in patients with advanced Parkinson's disease score in patients with advanced Parkinson's disease, make life more vibrant.
Detailed Photos
Our Advantages